相关实验视频

Updated: Jun 24, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.0K

化学抗原受体T细胞疗法用于自身免疫性疾病

James B Chung1, Jennifer N Brudno2, Dominic Borie1

  • 1Kyverna Therapeutics Inc., Emeryville, CA, USA.

Nature reviews. Immunology
|June 3, 2024
PubMed
概括

化学抗原受体 (CAR) T细胞疗法在血液癌症中取得了成功,通过向B细胞来治疗自身免疫性疾病有希望. 研究人员正在改进CAR T细胞策略,以获得更安全,更有效的自身免疫治疗.

更多相关视频

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.5K
Generation of Human Chimeric Antigen Receptor Regulatory T Cells10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.3K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514